𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and Safety of Donepezil in Patients with Alzheimer’s Disease

✍ Scribed by Mercè Boada-Rovira, Henry Brodaty, Patrick Cras, Stavros Baloyannis…

Book ID
120807242
Publisher
Springer International Publishing AG
Year
2004
Tongue
English
Weight
149 KB
Volume
21
Category
Article
ISSN
1170-229X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of donepezil over 3
Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease
✍ A. Burns; S. Gauthier; C. Perdomo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective This 132‐week, open‐label extension study assessed the long‐term efficacy and safety of donepezil in 579 patients with mild to moderate Alzheimer's disease (AD) who had previously participated in a 24‐week double‐blind study of 5 or 10 mg/day donepezil __vs__ placebo. ##

Efficacy and safety of donepezil in pati
Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial
✍ Howard Feldman; Serge Gauthier; Jane Hecker; Bruno Vellas; Yikang Xu; John R. Ie 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

## Abstract ## Background There have been very limited investigations of cholinesterase inhibitor therapy in more advanced stages of Alzheimer's disease (AD). The efficacy and safety of donepezil were evaluated in __post hoc__ analyses of a subgroup of patients with more severe AD (standardized Mi